Neural cell surface differentiation antigen gp130RB13‐6induces fibroblasts and glioma cells to express astroglial proteins and invasive properties

Publisher Website
Google Scholar
Abstract
Transient expression of the differentiation and tumor cell surface antigen gp130RB13-6 characterizes a subset of rat glial progenitor cells susceptible to ethylnitrosourea-induced neurooncogenesis. gp130RB13-6 is as a member of an emerging protein family of ecto-phosphodiesterases/nucleotide pyrophosphatases that includes PC-1 and the tumor cell motility factor autotaxin. We have investigated the potential role of gp130RB13-6 in glial differentiation by transfection of three cell lines of different origin that do not express endogenous gp130RB13-6 (NIH-3T3 mouse fibroblasts; C6 and BT7Ca rat glioma cells) with the cDNA encoding gp130RB13-6. The effect of gp130RB13-6 expression was analyzed in terms of overall cell morphology, the expression of glial cell-specific marker proteins, and invasiveness. Transfectant sublines, consisting of 100% gp130RB13-6-positive cells, exhibited an altered, bipolar morphology. Fascicular aggregates of fibroblastoid cells subsequently developed into mesh-like patterns. Contrary to the parental NIH-3T3 and BT7Ca cells, the transfectant cells invaded into collagen type I. As shown by immunofluorescence staining of the transfectant sublines as well as of primary cultures composed of gp130RB13-6-positive and -negative cells, expression of gp130RB13-6 induced coexpression of proteins typical for glial cells and their precursors, i.e., glial fibrillary acidic protein, the low affinity nerve growth factor receptor, and the neural proteins Thy-1, Ran-2, and S-100. In accordance with its expression in the immature rat nervous system, gp130RB13-6 may thus have a significant role in the glial differentiation program and its subversion in neurooncogenesis.—Deissler, H., Blass-Kampmann, S., Bruyneel, E., Mareel, M., Rajewsky, M. F. Neural cell surface differentiation antigen gp130RB13-6 induces fibroblasts and glioma cells to express astroglial proteins and invasive properties.
Funding Information
  • Deutsche Forschungsgemeinschaft (Ra 119/16-1)
  • Dr. Mildred Scheel Stiftung für Krebsforschung
  • National Foundation for Cancer Research
  • Fédération Wallonie-Bruxelles